Treatment of Hypertension With Adalat® in Combination With Other Drugs

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Antihypertensive Agents; Nifedipine

Criteria

Inclusion Criteria:

• Previously untreated hypertensive patients starting with combination therapy containing nifedipine or

• Insufficiently controlled hypertensive pts. receiving nifedipine as an add-on to existing non-CCB (calcium-channel-blocker) containing antihypertensive therapy

Exclusion Criteria:

• None. Exclusion criteria are defined by contraindications and precautions as stated in the local product information.